<DOC>
	<DOCNO>NCT00745368</DOCNO>
	<brief_summary>The purpose research study determine much raltegravir get male female genital tract .</brief_summary>
	<brief_title>Comparing Raltegravir Genital Tract Distribution HIV-infected Men Women</brief_title>
	<detailed_description>Although many medication fight HIV virus , little know much medication get genital tract . Raltegravir new HIV medication block HIV growth lower amount virus blood way different currently available HIV medication . Raltegravir recently approve Food Drug Administration ( FDA ) use HIV infect patient , little information concern much raltegravir reach genital tract men woman . The purpose research study determine much raltegravir get male female genital tract .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Documentation blood seropositive HIV base self report confirm ELISA Western blot detectable HIV RNA Stable antiretroviral regimen least 3 week prior enrollment Capable give informed consent Age 18 year old Neoplasms Women pregnant nursing History current evidence significant acute chronic medical illness opinion investigator would preclude subject safely participate study Current use phenobarbital , phenytoin , rifampin Any major surgery within 4 week enrollment Blood transfusion within 4 week enrollment Inability tolerate oral medication Inability tolerate venipuncture , venous access , genital tract sample History recent ( within 6 month ) drug alcohol abuse Evidence organ dysfunction clinically significant deviation normal medical history , physical examination , vital sign , clinical laboratory determination opinion investigator would preclude subject safely participate study Any sound medical , psychiatric social reason exclusion determine investigator History allergy study medication relate compound</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>HIV</keyword>
	<keyword>Raltegravir</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>